.40 on the HKSE. This SniperIQ fundamentals page covers Alibaba Health Information Technology's valuation (P/E 24.5x, P/B 2.7x), profitability (net margin 5.7%), revenue (¥34.3B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapHK$55.0B
P/E (TTM)24.5x
Net Margin5.7%
Revenue (FY26)¥34.3B

Full research coverage

Frequently Asked Questions

What is Alibaba Health Information Technology's market cap?

Alibaba Health Information Technology (0241) has a market capitalization of approximately HK$55.0B, trading at HK

.40 on the HKSE. Market cap moves with the live share price.

What is Alibaba Health Information Technology's P/E ratio?

Alibaba Health Information Technology's trailing twelve-month P/E ratio is 24.5x, with a price-to-book (P/B) of 2.7x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Alibaba Health Information Technology?

Alibaba Health Information Technology runs a net profit margin of 5.7%, a gross margin of 24.0%, and an operating margin of 5.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Alibaba Health Information Technology generate?

Alibaba Health Information Technology reported revenue of ¥34.3B for fiscal year 2026, with net income of ¥1.9B and earnings per share (EPS) of 0.12. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Alibaba Health Information Technology pay a dividend?

Alibaba Health Information Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Alibaba Health Information Technology financially healthy?

Alibaba Health Information Technology carries a debt-to-equity ratio of 0.00x and a current ratio of 3.03x, with a market beta of 1.59. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Alibaba Health Information Technology a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Alibaba Health Information Technology (0241) the key facts are: market cap HK$55.0B, P/E 24.5x, revenue ¥34.3B, 52-week range 3.04-7.91. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Alibaba Health Information Technology's full fundamentals live

Get Alibaba Health Information Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.